Tag: AHA 2019
Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results
George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial sess...
AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease
The largest trial to date to compare revascularisation with a conservative strategy in patients ...
AHA 2019: Preprocedural COLCHICINE-PCI finds a lowering of inflammation, but no reduction in myocardial injury
Preprocedural administration of an oral colchicine load does not reduce the risk of myocardial i...
AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor Sy...